Health


 Why Are Institutional Investors Adjusting Their Merck & Co. (NYSE:MRK) Holdings?

Why Are Institutional Investors Adjusting Their Merck & Co. (NYSE:MRK) Holdings?

February 04, 2025 03:04 AM PST| By Team Kalkine Media

Highlights,Institutional investors have adjusted their positions in Merck & Co., with some reducing stakes while others increased their holdings.,U.S. Capital Wealth Advisors LLC reduced its stake in Merck & Co. by 37.8% in the fourth quarter.,Severa...

 Is Eli Lilly (NYSE:LLY) Seeing Institutional Interest Shift?

Is Eli Lilly (NYSE:LLY) Seeing Institutional Interest Shift?

February 04, 2025 03:01 AM PST| By Team Kalkine Media

Highlights,SkyOak Wealth LLC adjusted its stake in Eli Lilly (NYSE:LLY) in the fourth quarter, reducing its position by a small margin.,Several other institutional firms also modified their holdings in the company during recent quarters.,Institutiona...

 Is Medtronic (NYSE:MDT) Seeing Increased Institutional Interest?

Is Medtronic (NYSE:MDT) Seeing Increased Institutional Interest?

February 04, 2025 02:58 AM PST| By Team Kalkine Media

Highlights,Institutional investors continue adjusting their positions in Medtronic (NYSE:MDT), with recent filings showing shifts in holdings.,The company maintains a strong presence in the medical technology sector, with a diversified portfolio of h...

 Tempus AI Completes Acquisition of Ambry Genetics to Advance Precision Medicine

Tempus AI Completes Acquisition of Ambry Genetics to Advance Precision Medicine

February 04, 2025 01:57 AM PST| By Team Kalkine Media

Highlights,Acquisition Deal Finalized:,Tempus AI acquired,Ambry Genetics,for,$600 million,in cash and stock.,Strategic Expansion:,The deal strengthens Tempus’ role in,AI-driven precision medicine and genetic testing,.,Ambry Genetics to Operate Indepe...

 Breaking Down the Latest Market Activity for CVS Health Corp (NYSE:CVS)

Breaking Down the Latest Market Activity for CVS Health Corp (NYSE:CVS)

February 04, 2025 12:00 AM PST| By Team Kalkine Media

Highlights,Evercore ISI raised CVS Health’s price target from $60.00 to $65.00.,Institutional investors continue adjusting holdings, reflecting market activity.,CVS Health maintains a strong dividend policy with an annualized yield of 4.73%.,CVS Heal...

 How Is Elevance Health (NYSE:ELV) Expanding Its Role in the Healthcare Industry

How Is Elevance Health (NYSE:ELV) Expanding Its Role in the Healthcare Industry

February 04, 2025 12:00 AM PST| By Team Kalkine Media

Highlights,Atomi Financial Group Inc. increased its stake in Elevance Health by a notable margin.,Elevance Health’s stock performance reflects steady movement with institutional backing.,Dividend payouts have risen, aligning with earnings growth and...

 How Is HCA Healthcare (NYSE:HCA) Strengthening Its Financial Position

How Is HCA Healthcare (NYSE:HCA) Strengthening Its Financial Position

February 04, 2025 12:00 AM PST| By Team Kalkine Media

Highlights,HCA Healthcare shares increased following a strong earnings report.,The company announced an earnings per share figure that exceeded expectations.,A dividend increase was declared, reinforcing financial stability.,HCA Holdings Inc. operate...

 How Is Cencora (NYSE:COR) Strengthening Its Position in Pharmaceutical Distribution

How Is Cencora (NYSE:COR) Strengthening Its Position in Pharmaceutical Distribution

February 04, 2025 12:00 AM PST| By Team Kalkine Media

Highlights,Institutional investors increase holdings in Cencora, reflecting market confidence.,Stock performance reaches a new high following financial updates.,Dividend payout rises, reinforcing the company’s financial approach.,Cencora Inc. operate...

 Is Chemed Corporation (NYSE:CHE) Expanding Its Operations Across Key Market Segments

Is Chemed Corporation (NYSE:CHE) Expanding Its Operations Across Key Market Segments

February 04, 2025 12:00 AM PST| By Team Kalkine Media

Highlights,Institutional investors adjust their holdings in Chemed Corporation, signaling market confidence.,Stock performance remains stable, with financial metrics supporting operational strength.,Dividend distributions continue, reinforcing financ...

 Why Is ResMed (NYSE:RMD) Gaining Market Attention Amid Financial Updates

Why Is ResMed (NYSE:RMD) Gaining Market Attention Amid Financial Updates

February 03, 2025 08:27 AM PST| By Team Kalkine Media

Highlights,ResMed announces strong financial performance with an increase in earnings per share.,The company maintains its dividend distribution strategy, reinforcing financial stability.,Stock transactions by corporate executives and institutional a...

 InflaRx (NASDAQ:IFRX) Experiences Notable Rise in Short Interest

InflaRx (NASDAQ:IFRX) Experiences Notable Rise in Short Interest

February 03, 2025 08:10 AM PST| By Team Kalkine Media

Highlights,Short interest rises by 15% in January, reaching 248,900 shares.,Stock opens at $2.41, reflecting a 1.7% increase.,Vilobelimab advances through key clinical stages.,InflaRx N.V. is part of,NASDAQ Healthcare Stocks,and focuses on developing...

 Burcon NutraScience (TSX:BU) Sees 5.6% Increase in Stock Price – Is It a Good Time to Invest?

Burcon NutraScience (TSX:BU) Sees 5.6% Increase in Stock Price – Is It a Good Time to Invest?

February 03, 2025 03:22 AM PST| By Team Kalkine Media

Burcon NutraScience Co. Sees Surge in Trading Volume

 Janney Montgomery Scott LLC Holds $2.01 Million in Hologic, Inc. (NASDAQ:HOLX) Investments

Janney Montgomery Scott LLC Holds $2.01 Million in Hologic, Inc. (NASDAQ:HOLX) Investments

February 03, 2025 12:59 AM PST| By Team Kalkine Media

Financial Insights: Hologic, Inc.'s Strategic Movements and Market Position

 SG Americas Securities LLC Acquires Shares of The Cooper Companies, Inc. (NASDAQ:COO)

SG Americas Securities LLC Acquires Shares of The Cooper Companies, Inc. (NASDAQ:COO)

February 03, 2025 12:21 AM PST| By Team Kalkine Media

Investment Shifts in Cooper Companies and Market Performance

 How Quest Diagnostics (NYSE:DGX) Is Navigating the Competitive Healthcare Sector

How Quest Diagnostics (NYSE:DGX) Is Navigating the Competitive Healthcare Sector

February 03, 2025 12:00 AM PST| By Team Kalkine Media

Highlights,Institutional investors increase holdings in Quest Diagnostics, signaling strong confidence.,Analysts from Barclays and Morgan Stanley adjust price targets, reflecting market sentiment.,Quest Diagnostics maintains a solid financial positio...

 Why Is Ultragenyx Pharmaceutical (NASDAQ:RARE) Gaining Attention Amid Market Changes

Why Is Ultragenyx Pharmaceutical (NASDAQ:RARE) Gaining Attention Amid Market Changes

February 02, 2025 12:00 AM PST| By Team Kalkine Media

Highlights,Institutional positions in Ultragenyx Pharmaceutical have shifted.,Revenue shows strong year-over-year growth.,Stock activity includes executive transactions and corporate movements.,Ultragenyx is part of,NASDAQ Healthcare Stocks,. Special...

 Is Centene Corp (NYSE:CNC) Strengthening Its Managed Healthcare Services

Is Centene Corp (NYSE:CNC) Strengthening Its Managed Healthcare Services

February 02, 2025 12:00 AM PST| By Team Kalkine Media

Highlights,Janney Montgomery Scott LLC increased its stake in Centene Corp, reflecting market adjustments.,Institutional firms made varied changes in their holdings, impacting stock activity.,Market performance reflects adjustments in financial posit...

 How Is Universal Health Services (NYSE:UHS) Navigating Financial and Market Trends

How Is Universal Health Services (NYSE:UHS) Navigating Financial and Market Trends

February 02, 2025 12:00 AM PST| By Team Kalkine Media

Highlights,Institutional firms adjusted their holdings in Universal Health Services, reflecting market activity.,Stock movement aligns with financial stability and ongoing market engagement.,The company maintains structured financial management with...

 How Is Thermo Fisher Scientific (NYSE:TMO) Managing Market Movements

How Is Thermo Fisher Scientific (NYSE:TMO) Managing Market Movements

February 02, 2025 12:00 AM PST| By Team Kalkine Media

Highlights,Price targets for Thermo Fisher Scientific continue to adjust, reflecting market sentiment.,A significant repurchase program signals confidence in valuation.,Strong backing from institutional investors underscores market strength.,Thermo F...

 Ocular Therapeutix (NASDAQ:OCUL) Strengthens Presence in Biopharmaceuticals

Ocular Therapeutix (NASDAQ:OCUL) Strengthens Presence in Biopharmaceuticals

January 31, 2025 09:15 AM PST| By Team Kalkine Media

Highlights,SG Americas Securities LLC raised its stake in Ocular Therapeutix by 58.7% in Q4.,A company executive transacted 2,948 shares, reducing by 1.08%.,Financial firms gave mixed ratings, with an average target price of $16.71.,Ocular Therapeuti...

Recent Articles






Investing Tips

Previous Next